struvite has been researched along with propionohydroxamic-acid* in 6 studies
6 other study(ies) available for struvite and propionohydroxamic-acid
Article | Year |
---|---|
Ureaplasma urealyticum as a causative organism of urinary tract infection stones.
Ureaplasma urealyticum is a fastidious organism which is not recovered by conventional bacterial cultures techniques, but special cultures are required for its isolation and identification. As it is a urease-producing organism, it is considered a risk factor for the formation of struvite calculi in the urinary tract. A total of 30 patients with urinary infection stones (19 of them with the 1st formation and 11 with recurrent stone formation) were included in the study. Both bladder urine specimen (cystoscopically obtained) and stones removed were subjected to conventional cultures and also to Ureaplasma specific cultures (A7 agar and U9 broth). The results of culture techniques revealed that 86.7% of patients had aerobic organisms (E. coli in 46.7%, Klebsiella in 30%, Proteus in 6.7% and Pseudomonas in 3.3%) and 26.7% showed U. urealyticum in mid stream urine. As regards stone cultures, they revealed aerobic organisms in 76.7%, and U. urealyticum in 20%. Sensitivity tests for U. urealyticum showed that minocycline was the most effective antimicrobial followed by tetracycline and ciprofloxacin. From these data, we conclude that U. urealyticum may be the causative organism for infection stone and should be searched for via its specific cultures, especially in patients with recurrent stones and with the so-called sterile pyuria. Topics: Adult; Anti-Bacterial Agents; Apatites; Bacterial Typing Techniques; Calcium Oxalate; Causality; Cystoscopy; Drug Therapy, Combination; Egypt; Female; Humans; Hydroxamic Acids; Magnesium Compounds; Male; Microbial Sensitivity Tests; Phosphates; Recurrence; Struvite; Ureaplasma Infections; Ureaplasma urealyticum; Urinalysis; Urinary Calculi; Urinary Tract Infections | 1996 |
Computerized in vivo research from the growth of urease-producing bacteria in the presence of antibiotics combined with propionhydroxamic acid.
Topics: Bacteriological Techniques; Bacteriuria; Computers; Drug Interactions; Humans; Hydroxamic Acids; Magnesium; Magnesium Compounds; Netilmicin; Phosphates; Proteus Infections; Proteus mirabilis; Struvite; Urease; Urinary Calculi | 1987 |
Propionhydroxamic acid in the management of struvite urinary stones.
Topics: Enterobacteriaceae Infections; Humans; Hydroxamic Acids; Hydroxyurea; Magnesium; Magnesium Compounds; Phosphates; Pseudomonas Infections; Struvite; Urease; Urinary Calculi; Urinary Tract Infections | 1987 |
Physicochemical changes of urine environment on propionhydroxamic acid therapy.
Topics: Adult; Ammonia; Bacterial Infections; Citrates; Female; Humans; Hydrogen-Ion Concentration; Hydroxamic Acids; Magnesium; Magnesium Compounds; Male; Middle Aged; Phosphates; Struvite; Urease; Urinary Calculi | 1987 |
Low-dose propionhydroxamic acid therapy in infection-induced stones.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Hydrogen-Ion Concentration; Hydroxamic Acids; Kidney Calculi; Magnesium; Magnesium Compounds; Male; Middle Aged; Phosphates; Struvite; Urease; Urinary Tract Infections | 1987 |
Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones.
The use of drugs inhibiting bacterial urease represents an interesting improvement in preventive treatment of renal infected stones. The low dose (120 mg/day) for one week followed by 60 mg/day of propionohydroxamic acid (PHA) has shown excellent anti-urease activity. The nearly normal absence of side effects also allows long-term administration. Topics: Humans; Hydroxamic Acids; Kidney Calculi; Magnesium; Magnesium Compounds; Phosphates; Struvite; Urinary Tract Infections | 1986 |